secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2026-01-16T23:59:59+00:00
Accession:  0001437749-26-001455
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

NRx Pharmaceuticals Receives Nasdaq Non-Compliance Notice for Delayed Annual Meeting; Sets 2025 Meeting
--------------------------------------------------------------------------------

- Received Nasdaq letter on Jan 12, 2026 for failing to hold annual meeting within 12 months of fiscal year end.
- Company has 45 days to submit a plan to regain compliance; Nasdaq may grant exception until June 29, 2026.
- Annual meeting set for March 23, 2026 with record date of February 12, 2026.
- Stock continues trading under symbol NRXP; non-compliance indicator will be broadcast after five business days.
- Stockholder proposals or director nominations must be received by January 26, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774926001455/0001437749-26-001455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774926001455/nrxp20260115_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-001455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer